These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 37211261

  • 21. Assessment of the effectiveness of three different cephalosporin/clavulanate combinations for the phenotypic confirmation of extended-spectrum beta-lactamase producing bacteria isolated from urine samples at National Public Health Laboratory, Kathmandu, Nepal.
    Bhandari R, Pant ND, Poudel A, Sharma M.
    BMC Res Notes; 2016 Aug 04; 9():390. PubMed ID: 27488224
    [Abstract] [Full Text] [Related]

  • 22. Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Lampri N, Galani I, Poulakou G, Katsarolis I, Petrikkos G, Giamarellou H, Souli M.
    J Antimicrob Chemother; 2012 Oct 04; 67(10):2424-8. PubMed ID: 22665388
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prevalence of extended spectrum beta lactamase and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Gram negative bacilli isolates from pediatric patient population in Gaza strip.
    El Aila NA, Al Laham NA, Ayesh BM.
    BMC Infect Dis; 2023 Feb 20; 23(1):99. PubMed ID: 36803466
    [Abstract] [Full Text] [Related]

  • 29. Evolution of TEM-type extended-spectrum β-lactamases in Escherichia coli by cephalosporins.
    Clasen J, Birkegård AC, Græsbøll K, Folkesson A.
    J Glob Antimicrob Resist; 2019 Dec 20; 19():32-39. PubMed ID: 31048029
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
    Tello M, Ocejo M, Oporto B, Hurtado A.
    Appl Environ Microbiol; 2020 Jul 20; 86(15):. PubMed ID: 32471914
    [Abstract] [Full Text] [Related]

  • 34. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology.
    Queenan AM, Foleno B, Gownley C, Wira E, Bush K.
    J Clin Microbiol; 2004 Jan 20; 42(1):269-75. PubMed ID: 14715764
    [Abstract] [Full Text] [Related]

  • 35. Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species.
    Kohner PC, Robberts FJ, Cockerill FR, Patel R.
    J Clin Microbiol; 2009 Aug 20; 47(8):2419-25. PubMed ID: 19494061
    [Abstract] [Full Text] [Related]

  • 36. Selection of the appropriate avibactam concentration for use with ceftibuten in broth microdilution susceptibility testing.
    Sader HS, Lindley J, Deshpande LM, Doyle T, Castanheira M.
    Diagn Microbiol Infect Dis; 2022 Jun 20; 103(2):115673. PubMed ID: 35390644
    [Abstract] [Full Text] [Related]

  • 37. In vitro activity of flomoxef against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Korea.
    Jung Y, Lee SS, Song W, Kim HS, Uh Y.
    Diagn Microbiol Infect Dis; 2019 May 20; 94(1):88-92. PubMed ID: 30658867
    [Abstract] [Full Text] [Related]

  • 38. Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019-2020).
    Mendes RE, Arends SJR, Streit JM, Critchley I, Cotroneo N, Castanheira M.
    Microbiol Spectr; 2023 Feb 14; 11(1):e0205722. PubMed ID: 36625644
    [Abstract] [Full Text] [Related]

  • 39. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM.
    J Antimicrob Chemother; 2007 Aug 14; 60(2):300-11. PubMed ID: 17548456
    [Abstract] [Full Text] [Related]

  • 40. Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations.
    Luzzaro F, Perilli M, Amicosante G, Lombardi G, Belloni R, Zollo A, Bianchi C, Toniolo A.
    Int J Antimicrob Agents; 2001 Feb 14; 17(2):131-5. PubMed ID: 11165117
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.